Menu

Strawberry Creek Ventures Community Newsletter — January 2023

Content at the intersection of entrepreneurship, venture capital, and our UC Berkeley community.

UC Berkeley with Berkeley and bay in background
Written by

Matt Caspari

Published on

Read

2 min

IN THIS ISSUE: Last call for Fund 6; discussion on how to diversify into VC in 2023 on January 18 and 20, join a Haas poker championship on 1/26; portfolio company news on Gilgamesh Pharmaceuticals, Divergent, Dataminr, FreeWire, and Finwave; learn about the latest advances in AI and ML on 1/26; and more.

Last Chance to Join Strawberry Creek Fund 6!

Don’t miss your chance to invest! Strawberry Creek Fund 6 is closing at the end of the month. If you would like to learn more, connect with us 1×1 or join an upcoming discussion about diversifying into VC with Matt Caspari on January 18 or 20. You can also visit our secure portal to access all fund materials. 

Strawberry Creek Ventures: Diversify into VC in 2023

Join us for an upcoming live discussion on Wednesday, January 18, at 1:00 PM PT or Friday, January 20, at 11:00 AM PT to learn about the goal and structure of the fund, recent investment activity, and the benefits of diversifying into VC in 2023. Click below to learn more and register.

UPCOMING EVENT

Haas Poker Championship at Strawberry Creek Ventures’ Office

Thursday, January 26, 6:00 PM PT in Menlo Park

Join us for an evening of friendly competition, fun, meeting new people, and an opportunity to support the Haas Annual Fund!

Strawberry Creek Portfolio Company News

Gilgamesh Pharmaceutical is working to reshape the treatment of mental illness by creating a portfolio of novel compounds that capture the therapeutic benefits of psychedelics. Strawberry Creek Ventures deployed capital in the company’s recent $39 million series B led by Prime Movers Lab. The capital will help advance Gilgamesh’s two lead programs for novel, patented antidepressants through efficacy studies. Strawberry Creek also invested in the company’s $27 million series A in May 2021, led by Prime Movers Lab.

MORE PORTFOLIO NEWS:
UPCOMING WEBINAR

The Latest Advances in AI and Machine Learning

Thursday, January 26, 11:00 AM PT/ 2:00 PM ET

Join Managing Partner Matt Caspari and three founders of leading AI companies in the Alumni Ventures portfolio (Chooch, Synthesis AI, and DataHeroes) as they discuss the latest advances in AI, the exciting potential of innovating companies in this sector, and the impact of AI-related technology.

FOR CURRENT INVESTORS

Thinking of becoming an investor? Access Materials »

Visit Your Club Portal

We invite existing investors to visit your Club portal for updates from Managing Partner Matt Caspari and our team, including webinars and events, Syndications, portfolio news, and more. Visit Club Portal »

What’s New at Alumni Ventures

Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit av-funds.com/disclosures.

Written by

Matt Caspari

Matt is a two-time venture-backed founder/CEO with a decade of startup operating experience. Before joining Strawberry Creek Ventures, he was an Investing Partner at Spike Ventures, where he participated in over twenty investments. Matt holds an MBA with a Certificate in Entrepreneurship from UC Berkeley’s Haas School of Business and a BS in Biochemistry from Georgetown University.

Video
Tagged with

Follow us

AV Headquarters
670 N. Commercial Street
Suite 403
Manchester, NH 03101
General inquiries: [email protected]

Press inquiries: [email protected]

603-518-8112

Follow us

Neither Alumni Ventures nor any of its fund are sponsored by, affiliated with, or endorsed by any school. Venture capital investing involves substantial risk, including risk of loss of all capital invested. Achievement of investment objectives cannot be guaranteed. Past performance does not guarantee future results. To see information on all AV fund investment performance, please see here. To see additional risk factors and considerations, see: here.

No content hosted on this website is an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are made only pursuant to the formal offering documents for the funds concerned, which describe the risks, terms, and other important information that must be carefully considered before an investment is made. Alumni Ventures and its affiliates provide advice only to venture capital funds affiliated with AV. No information on this website may be relied upon as personalized advice to any recipient.

Please see Alumni Ventures’ Legal & Privacy Policy here and additional Investor Policies here.

Testimonial/Endorsement Policy: Testimonials/Endorsements were provided by the participants without compensation, but each participant has a relationship with Alumni Ventures (AV) from which they benefit. All views expressed are the individual’s own and do not represent the experience of all AV fund investors or companies in which AV funds invest. Please note that testimonials are no guarantee of future performance or success. Any provider of an endorsement that is affiliated with a portfolio company Alumni Ventures has received investment funding from AV, and may in the future seek and/or receive additional funding from AV. This circumstance constitutes a conflict of interest. Providers of testimonials or endorsements were not chosen at random or according to any objective basis, but rather on the basis of their relationship with AV.

Alumni Ventures is America’s largest VC firm for individual investors based on the combination of total capital raised, number of investments, and number of investors of leading VC firms as reported by Pitchbook and other publicly available information reviewed by AV.

Video Policy: By consuming this content I acknowledge that I may be considering an investment with AV funds for my own or my client’s account. I agree that information contained herein may not be relied upon or used for any other purpose.

© 2025, Alumni Ventures. All rights reserved.